Iovance Biotherapeutics (IOVA) Change in Receivables (2023 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Change in Receivables of -$690000.0 for Q1 2026, down 143.18% year-over-year from $1.6 million in Q1 2025, and down 104.4% quarter-over-quarter from $15.7 million in Q4 2025.
Iovance Biotherapeutics (IOVA) Change in Receivables (2023 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Change in Receivables for 4 consecutive years, with -$690000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables fell 143.18% year-over-year to -$690000.0; the TTM figure through Mar 2026 stood at $10.8 million (down 84.7% YoY), while the FY2025 annual figure was $13.1 million, down 81.05% from the prior year.
- Change in Receivables fell to -$690000.0 in Q1 2026 per IOVA's latest filing, from $15.7 million in the prior quarter.
- Across five years, Change in Receivables topped out at $31.4 million in Q2 2024 and bottomed at -$11.0 million in Q2 2025.
- Historically, Change in Receivables has averaged $6.8 million across 4 years, with a median of $873500.0 in 2023.
- Annual changes were most pronounced in 2024 — Change in Receivables surged 94960.61% — and 2026, when it tumbled 143.18%.
- Iovance Biotherapeutics' Change in Receivables stood at $149000.0 in 2023, then surged by 9008.72% to $13.6 million in 2024, then increased by 15.58% to $15.7 million in 2025, then tumbled by 104.4% to -$690000.0 in 2026.
- Business Quant data shows IOVA's Change in Receivables at -$690000.0 in Q1 2026, $15.7 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn | 20.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.36 Mn |
| Jun 30, 2026 | 20.36 Mn |
| Mar 31, 2026 | -690,000.00 |
| Mar 31, 2026 | -690,000.00 |
| Dec 31, 2025 | 15.69 Mn |
| Dec 31, 2025 | 15.69 Mn |
| Sep 30, 2025 | 6.82 Mn |
| Sep 30, 2025 | 6.82 Mn |
| Jun 30, 2025 | -11.00 Mn |
| Jun 30, 2025 | -11.00 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 13.57 Mn |
| Dec 31, 2024 | 13.57 Mn |
| Sep 30, 2024 | 24.16 Mn |
| Sep 30, 2024 | 24.16 Mn |
| Jun 30, 2024 | 31.37 Mn |
| Jun 30, 2024 | 31.37 Mn |
| Mar 31, 2024 | 83,000.00 |
| Mar 31, 2024 | 83,000.00 |